$IMNN
Imunon, Inc. Stock $imnn

$imnn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223009604 Filed on March 30, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue		$130.0K	$500.0K
YoY Change		4.0%	0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.060M	$4.050M	$13.69M
YoY Change	6.56%	54.01%	25.74%
% of Gross Profit
Research & Development	$2.620M	$3.000M	$11.73M
YoY Change	-15.37%	0.46%	10.49%
% of Gross Profit
Depreciation & Amortization	$192.7K	$220.0K	$731.6K
YoY Change	10.74%	37.35%	4.08%
% of Gross Profit
Operating Expenses	$5.684M	$7.050M	$25.42M
YoY Change	-4.73%	25.54%	18.2%
Operating Profit	-$5.684M		-$24.92M
YoY Change	-2.7%		18.63%
Interest Expense	$90.00K	$100.0K	$5.029M
YoY Change	-101.94%	-210.94%	-999.77%
% of Operating Profit
Other Income/Expense, Net	$93.09K	$5.400M	-$12.54M
YoY Change	5071.39%	176.59%	-872.44%
Pretax Income	-$5.590M	-$14.80M	-$37.47M
YoY Change	-46.63%	164.06%	69.12%
Income Tax		-$1.570M	-$1.567M
% Of Pretax Income
Net Earnings	-$5.591M	-$13.23M	-$35.90M
YoY Change	-46.62%	213.41%	72.84%
Net Earnings / Revenue		-10176.92%	-7179.65%
Basic Earnings Per Share	-$0.68		-$5.03
Diluted Earnings Per Share	-$0.68	-$1.52	-$5.03
COMMON SHARES
Basic Shares Outstanding	9.090M shares	7.434M shares	7.143M shares
Diluted Shares Outstanding	8.281M shares		7.143M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.18M	$32.75M	$34.25M
YoY Change	-24.52%	-33.7%	-30.65%
Cash & Equivalents	$10.40M	$11.49M	$11.49M
Short-Term Investments	$20.78M	$21.25M	$22.75M
Other Short-Term Assets	$2.790M	$2.780M	$2.780M
YoY Change	9.63%	13.59%	13.59%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$36.33M	$37.15M	$37.15M
YoY Change	-17.18%	-28.47%	-28.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$555.9K	$548.3K	$700.0K
YoY Change	-47.05%	14.95%	-40.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.750M	$4.500M	$4.500M
YoY Change	-37.5%	-25.0%	-25.0%
Other Assets	$5.218M	$6.273M	$1.620M
YoY Change	8780.23%	-70.99%	3.39%
Total Long-Term Assets	$5.774M	$6.821M	$6.830M
YoY Change	-71.8%	-69.14%	-69.1%
TOTAL ASSETS
Total Short-Term Assets	$36.33M	$37.15M	$37.15M
Total Long-Term Assets	$5.774M	$6.821M	$6.830M
Total Assets	$42.11M	$43.98M	$43.98M
YoY Change	-34.56%	-40.61%	-40.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.973M	$3.587M	$3.590M
YoY Change	14.39%	40.8%	40.94%
Accrued Expenses	$3.914M	$4.795M	$5.030M
YoY Change	39.78%	51.09%	35.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.180M	$1.420M	$1.420M
YoY Change
Total Short-Term Liabilities	$10.42M	$10.04M	$10.04M
YoY Change	56.7%	48.27%	48.31%
LONG-TERM LIABILITIES
Long-Term Debt	$3.900M	$4.610M	$4.610M
YoY Change	-33.9%	-21.26%	-21.26%
Other Long-Term Liabilities	$1.140M	$0.00	$0.00
YoY Change	-79.38%	-100.0%	-100.0%
Total Long-Term Liabilities	$5.040M	$4.610M	$4.610M
YoY Change	-55.9%	-59.85%	-59.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.42M	$10.04M	$10.04M
Total Long-Term Liabilities	$5.040M	$4.610M	$4.610M
Total Liabilities	$15.46M	$14.65M	$14.65M
YoY Change	-14.48%	-19.74%	-19.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$374.3M	-$369.0M
YoY Change		10.89%
Common Stock	$90.97K	$74.36K
YoY Change		28.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$85.19K	$85.19K
YoY Change		0.0%
Treasury Stock Shares		22.00 shares
Shareholders Equity	$26.65M	$29.33M	$29.33M
YoY Change
Total Liabilities & Shareholders Equity	$42.11M	$43.98M	$43.98M
YoY Change	-34.56%	-40.61%	-40.61%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$5.591M	-$13.23M	-$35.90M
YoY Change	-46.62%	213.41%	72.84%
Depreciation, Depletion And Amortization	$192.7K	$220.0K	$731.6K
YoY Change	10.74%	37.35%	4.08%
Cash From Operating Activities	-$4.086M	-$5.060M	-$23.13M
YoY Change	-48.78%	-0.55%	42.58%
INVESTING ACTIVITIES
Capital Expenditures	$57.14K	$50.00K	$267.8K
YoY Change	-202.24%	-295.01%	-185.94%
Acquisitions
YoY Change
Other Investing Activities	$580.0K	-$10.79M	$8.580M
YoY Change	-96.55%	1037.18%	-128.78%
Cash From Investing Activities	$519.3K	-$10.83M	$8.315M
YoY Change	-96.9%	1011.36%	-127.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.723M
YoY Change			-87.6%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.474M	440.0K	$6.723M
YoY Change			-87.73%
NET CHANGE
Cash From Operating Activities	-$4.086M	-5.060M	-$23.13M
Cash From Investing Activities	$519.3K	-10.83M	$8.315M
Cash From Financing Activities	$2.474M	440.0K	$6.723M
Net Change In Cash	-$1.092M	-15.45M	-$8.093M
YoY Change		154.84%	-196.1%
FREE CASH FLOW
Cash From Operating Activities	-$4.086M	-$5.060M	-$23.13M
Capital Expenditures	$57.14K	$50.00K	$267.8K
Free Cash Flow	-$4.143M	-$5.110M	-$23.40M
YoY Change	-47.7%	0.94%	47.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill		usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000749647
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock		usd
CY2021	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	IMNN	Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptions		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	IMNN	Payments On Notes Payable Including Endofterm Fees PaymentsOnNotesPayableIncludingEndoftermFees		usd
CY2022	IMNN	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
CY2022	IMNN	Stock Issued During Period Value Issuance Of Preferred Stock Upon Financing StockIssuedDuringPeriodValueIssuanceOfPreferredStockUponFinancing		usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments		pure
CY2022Q4	IMNN	Earnout Milestone Liability EarnoutMilestoneLiability		usd
CY2022Q4	IMNN	Lessee Operating Lease Liability Payments Due After Year One And There After LesseeOperatingLeaseLiabilityPaymentsDueAfterYearOneAndThereAfter		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-15911
CY2022	dei	Entity Registrant Name EntityRegistrantName	IMUNON, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-1256615
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	997 LENOX DRIVE
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 100
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	LAWRENCEVILLE
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08648
CY2022	dei	City Area Code CityAreaCode	(609)
CY2022	dei	Local Phone Number LocalPhoneNumber	896-9100
CY2022	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.01 Per Share
CY2022	dei	Trading Symbol TradingSymbol	IMNN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	13100000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9089789	shares
CY2022	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2022	dei	Auditor Location AuditorLocation	Princeton, New Jersey
CY2022	dei	Auditor Firm AuditorFirmId	100
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11492841	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19586272	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21254485	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29803095	usd
CY2022Q4	us-gaap	Debt Securities Held To Maturity Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss	128932	usd
CY2021Q4	us-gaap	Debt Securities Held To Maturity Accrued Interest After Allowance For Credit Loss DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss	108844	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	1500000	usd
CY2022Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	2778433	usd
CY2021Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	2447413	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	37154691	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	51945624	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	548301	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	477011	usd
CY2022Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	4500000	usd
CY2021Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	6000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1567026	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1383446	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	13366234	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	155876	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	690995	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	50000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	183489	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6272902	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21624164	usd
CY2022Q4	us-gaap	Assets Assets	43975894	usd
CY2021Q4	us-gaap	Assets Assets	74046799	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3586623	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2547251	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4794936	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3173537	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1424774	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	230749	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	548870	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	500000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10037082	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6769658	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5396000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	4610946	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	5854461	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	230749	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14648028	usd
CY2021Q4	us-gaap	Liabilities Liabilities	18250868	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	112500000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	112500000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7436219	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5770538	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7436197	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5770516	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	74362	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	57705	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	397980023	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	388600979	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	26494	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7974	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368667825	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-332769591	usd
CY2022Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	29413054	usd
CY2021Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	55881119	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	22	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	22	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	85188	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	85188	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29327866	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55795931	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43975894	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	74046799	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	500000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	500000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11733666	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10619287	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13687899	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10887903	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	25421565	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	21507190	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-24921565	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-21007190	usd
CY2022	IMNN	Gain Loss From Change In Earnout Milestone Liability GainLossFromChangeInEarnoutMilestoneLiability	5396000	usd
CY2021	IMNN	Gain Loss From Change In Earnout Milestone Liability GainLossFromChangeInEarnoutMilestoneLiability	1622000	usd
CY2022	IMNN	Impairment Of Goodwill And Inprocess Research And Development ImpairmentOfGoodwillAndInprocessResearchAndDevelopment	13366234	usd
CY2021	IMNN	Impairment Of Goodwill And Inprocess Research And Development ImpairmentOfGoodwillAndInprocessResearchAndDevelopment	1976101	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-234419	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	453356	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	10996	usd
CY2022	us-gaap	Interest Expense InterestExpense	5028618	usd
CY2021	us-gaap	Interest Expense InterestExpense	569881	usd
CY2022	us-gaap	Other Income OtherIncome	1801	usd
CY2021	us-gaap	Other Income OtherIncome	1899	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12543695	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1145506	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37465260	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22152696	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1567026	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1383446	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35898234	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20769250	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.83
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7142970	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5426953	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35898234	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20769250	usd
CY2022	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-43508	usd
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-7149	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17014	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	825	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	26494	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	7974	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35871740	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20761276	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35898234	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20769250	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	731629	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	702918	usd
CY2022	IMNN	Gain Loss From Change In Earnout Milestone Liability GainLossFromChangeInEarnoutMilestoneLiability	5396000	usd
CY2021	IMNN	Gain Loss From Change In Earnout Milestone Liability GainLossFromChangeInEarnoutMilestoneLiability	1622000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2673034	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3759737	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	462377	usd
CY2022	IMNN	Impairment Of Goodwill And Inprocess Research And Development ImpairmentOfGoodwillAndInprocessResearchAndDevelopment	13366234	usd
CY2021	IMNN	Impairment Of Goodwill And Inprocess Research And Development ImpairmentOfGoodwillAndInprocessResearchAndDevelopment	1976101	usd
CY2022	IMNN	Amortization Of Deferred Finance Charges And Debt Discount Associated With Note Payable AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable	181259	usd
CY2021	IMNN	Amortization Of Deferred Finance Charges And Debt Discount Associated With Note Payable AmortizationOfDeferredFinanceChargesAndDebtDiscountAssociatedWithNotePayable	237258	usd
CY2022	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	20088	usd
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	108844	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	514600	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	786718	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-133489	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	124728	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1039372	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	302404	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1072529	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	247142	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-500000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-500000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-23131376	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16223603	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	48191922	usd
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	53811069	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	56775000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	24000000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	267800	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	311613	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8315278	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30122682	usd
CY2022	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	28500000	usd
CY2022	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	28500000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6722667	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	52688946	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1508666	usd
CY2021	IMNN	Proceeds From Issuance Of Common Stock Upon Exercise Of Stock Options ProceedsFromIssuanceOfCommonStockUponExerciseOfStockOptions	4725	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5756630	usd
CY2021	IMNN	Payments On Notes Payable Including Endofterm Fees PaymentsOnNotesPayableIncludingEndoftermFees	5190587	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6722667	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	54768380	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8093431	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8422095	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25586272	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17164177	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17492841	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25586272	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4847359	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	357277	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	601495	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	568269	usd
CY2022	IMNN	Realized And Unrealized Gains And Losses Net On Investment In Debt Securities RealizedAndUnrealizedGainsAndLossesNetOnInvestmentInDebtSecurities	26494	usd
CY2021	IMNN	Realized And Unrealized Gains And Losses Net On Investment In Debt Securities RealizedAndUnrealizedGainsAndLossesNetOnInvestmentInDebtSecurities	7974	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55795931	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35898234	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6722654	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	13	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	34468	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2673034	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29327866	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	18611081	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20769250	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	52688946	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4725	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1508666	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-7974	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3759737	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	55795931	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21254485	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zU3TthjR0Iib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zTQbtXLALHba">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On an ongoing basis, the Company evaluates its estimates using historical experience and other factors, including the current economic environment. Significant items subject to such estimates are assumptions used for purposes of determining stock-based compensation, the fair value of the earn-out milestone liabilities, estimates for contingent liabilities, if any, and accounting for impairment of in-process research and development assets and goodwill evaluation. Management believes its estimates to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29803095	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	21227991	usd
CY2022	us-gaap	Depreciation Depreciation	197000	usd
CY2021	us-gaap	Depreciation Depreciation	130000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21254485	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	29811069	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29803095	usd
CY2022	IMNN	Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards	988389	shares
CY2021	IMNN	Number Of Shares Of Common Stock Issuable Upon Exercise Of Warrants And Equity Awards NumberOfSharesOfCommonStockIssuableUponExerciseOfWarrantsAndEquityAwards	618800	shares
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-369000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	32800000	usd
CY2022	IMNN	Proceeds From Sale Of Net Operating Losses ProceedsFromSaleOfNetOperatingLosses	1600000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	6000000.0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1600000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1400000	usd
CY2022Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Amortized Cost DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost	4005559	usd
CY2022Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Fair Value DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue	3994590	usd
CY2021Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Amortized Cost DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsAmortizedCost	19798177	usd
CY2021Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Within Three Months Fair Value DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingWithinThreeMonthsFairValue	19799835	usd
CY2022Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Amortized Cost DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost	17222432	usd
CY2022Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Fair Value DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue	17259895	usd
CY2021Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Amortized Cost DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsAmortizedCost	10012892	usd
CY2021Q4	IMNN	Debt Securities Availableforsale Maturity Allocated And Single Maturity Date Rolling Between Three And Twelve Months Fair Value DebtSecuritiesAvailableforsaleMaturityAllocatedAndSingleMaturityDateRollingBetweenThreeAndTwelveMonthsFairValue	10003260	usd
CY2022Q4	IMNN	Available For Sale Debt Securities Amortized Cost Basis Current AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent	21227991	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	21254485	usd
CY2021Q4	IMNN	Available For Sale Debt Securities Amortized Cost Basis Current AvailableForSaleDebtSecuritiesAmortizedCostBasisCurrent	29811069	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	29803095	usd
CY2022Q4	IMNN	Available For Sale Securities Unrealized Gains Fair Value AvailableForSaleSecuritiesUnrealizedGainsFairValue	13278505	usd
CY2022Q4	IMNN	Available For Sale Securities Unrealized Holding Gains Less Than Twelve Months AvailableForSaleSecuritiesUnrealizedHoldingGainsLessThanTwelveMonths	43508	usd
CY2021Q4	IMNN	Available For Sale Securities Unrealized Gains Fair Value AvailableForSaleSecuritiesUnrealizedGainsFairValue	8999580	usd
CY2021Q4	IMNN	Available For Sale Securities Unrealized Holding Gains Less Than Twelve Months AvailableForSaleSecuritiesUnrealizedHoldingGainsLessThanTwelveMonths	3499	usd
CY2022Q4	IMNN	Available For Sale Securities Unrealized Loss Fair Value AvailableForSaleSecuritiesUnrealizedLossFairValue	7975980	usd
CY2022Q4	IMNN	Available For Sale Securities Unrealized Holding Losses Less Than Twelve Months AvailableForSaleSecuritiesUnrealizedHoldingLossesLessThanTwelveMonths	-17014	usd
CY2021Q4	IMNN	Available For Sale Securities Unrealized Loss Fair Value AvailableForSaleSecuritiesUnrealizedLossFairValue	20803515	usd
CY2021Q4	IMNN	Available For Sale Securities Unrealized Holding Losses Less Than Twelve Months AvailableForSaleSecuritiesUnrealizedHoldingLossesLessThanTwelveMonths	-11473	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	21254485	usd
CY2022Q4	IMNN	Available For Sale Securities Unrealized Holding Gains Losses Less Than Twelve Months AvailableForSaleSecuritiesUnrealizedHoldingGainsLossesLessThanTwelveMonths	26494	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29803095	usd
CY2021Q4	IMNN	Available For Sale Securities Unrealized Holding Gains Losses Less Than Twelve Months AvailableForSaleSecuritiesUnrealizedHoldingGainsLossesLessThanTwelveMonths	-7974	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	502578	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	18145	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-49222	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-7149	usd
CY2022	IMNN	Investment Income Loss Nonoperating InvestmentIncomeLossNonoperating	453356	usd
CY2021	IMNN	Investment Income Loss Nonoperating InvestmentIncomeLossNonoperating	10996	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	35720	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	5964280	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	70128000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	91519974	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11492841	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19586272	usd
CY2022Q4	us-gaap	Restricted Investments RestrictedInvestments	6000000	usd
CY2021Q4	us-gaap	Restricted Investments RestrictedInvestments	6000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17492841	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25586272	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2000000.0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3192063	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3832749	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2643762	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3355738	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	548301	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	477011	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	2196711	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	1401356	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2139927	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1636727	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	37583	usd
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	16792	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	215402	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	87250	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	205313	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	31412	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4794936	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3173537	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1500000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3000000	usd
CY2022Q4	IMNN	Long Term Debt Maturities Repayments Of Principal Year Four And There After LongTermDebtMaturitiesRepaymentsOfPrincipalYearFourAndThereAfter	1500000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6000000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1567026	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1383446	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1567026	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1383446	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.071	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.078	pure
CY2022	IMNN	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.298	pure
CY2021	IMNN	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.150	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.538	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.076	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.046	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.062	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	79800000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	64915000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	13287000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	5213000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	93087000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	168519	shares
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	68744554	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1567026	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1383446	usd
CY2021	IMNN	Net Operating Losses Carryforward Limits Description NetOperatingLossesCarryforwardLimitsDescription	the deduction for net operating losses incurred in tax years beginning after January 1, 2018 is limited to 80% of annual taxable income. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act provides for economic and cash liquidity stimulus through various means including payroll tax credits, payroll tax deferral, short-term changes in tax deductibility of interest expenses among other things. The Act also permits NOL carryovers and carrybacks to offset 100% of taxable income for taxable years beginning before 2021. Previously, NOLs generated after December 31, 2017 were limited to 80% of taxable income in future years. In addition, the CARES Act allows NOLs incurred in 2018 through 2021 to be carried back to each of the five preceding tax years. The Company evaluated the various aspects of the Cares Act and determined that there was no material effect on the Financial Statements.
CY2021	IMNN	Net Operating Losses Expiration Description NetOperatingLossesExpirationDescription	expire starting in 2029 through 2041
CY2011Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4200000	usd
CY2011Q3	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	90000000	usd
CY2013Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1400000	usd
CY2013Q1	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	34000000	usd
CY2013Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1500000	usd
CY2013Q2	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	4000000	usd
CY2015Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1600000	usd
CY2015Q2	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	40000000	usd
CY2017Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	300000	usd
CY2017Q1	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	35000000	usd
CY2017Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	300000	usd
CY2017Q2	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	7000000	usd
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	800000	usd
CY2017Q4	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	5000000	usd
CY2018Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1500000	usd
CY2018Q3	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	30000000	usd
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	800000	usd
CY2018Q3	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	15000000	usd
CY2020Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2000000.0	usd
CY2021Q1	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	40000000	usd
CY2021Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	28000000.0	usd
CY2021Q1	IMNN	Operating Loss Carry Forwards Limitation On Use OperatingLossCarryForwardsLimitationOnUse	30000000	usd
CY2021Q1	IMNN	Shelf Registration Statement Amount ShelfRegistrationStatementAmount	100000000	usd
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On February 28, 2022, the Company effected a 15-for-1 reverse stock split of its common stock which was made effective for trading purposes as of the commencement of trading on March 31, 2022. As of that date, each 15 shares of issued and outstanding common stock and equivalents was consolidated into one share of common stock. All shares have been restated to reflect the effects of the 15-for-1 reverse stock split. In addition, at the market open on March 1, 2022, the Company’s common stock started trading under a new CUSIP number 15117N602 although the Company’s ticker symbol, CLSN, remained unchanged.
CY2022Q4	IMNN	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	19.78
CY2022Q4	IMNN	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue	0	usd
CY2022	IMNN	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4059	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	31.05
CY2020Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	213333	shares
CY2021	us-gaap	Stockholders Equity Note Changes In Capital Structure Retroactive Impact StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpact	To continue listing on The NASDAQ Capital Market, which requires that the Company comply with the applicable listing requirements under NASDAQ Marketplace Rules, which requirements include, among others, a minimum bid price of at least $1.00 per share. On December 2, 2021, the Company received a letter from NASDAQ indicating that the closing bid price of the Company’s Common Stock fell below $1.00 per share for the previous 30 consecutive business days, and that the Company was therefore not in compliance with the minimum bid price requirement for continued inclusion on The NASDAQ Capital Market. The Company had 180 calendar days, until May 31, 2022, to regain compliance with this requirement, which occurs when the closing bid price of the Company’s Common Stock is at least $1.00 per share for a minimum of ten consecutive business days during the 180-day compliance period
CY2022	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	5770516	shares
CY2022Q1	us-gaap	Share Price SharePrice	285
CY2022Q1	IMNN	Original Issue Discount Rate OriginalIssueDiscountRate	5	pure
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	300
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	14250000	usd
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	300
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1000000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	83	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.45
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1464	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.48
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	66	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	33.30
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1481	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	12.36
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	69650	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.92
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1381	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	12.04
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	100	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	9.45
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	69650	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.92
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	760220	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	201935	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0174	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0397	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0154	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0174	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.000	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.139	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.068	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.132	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	700000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M6D
CY2020Q4	IMNN	Earnout Milestone Liability EarnoutMilestoneLiability	7018000	usd
CY2021	IMNN	Gain Loss From Change In Fair Value Of Earn Out Milestone Liability GainLossFromChangeInFairValueOfEarnOutMilestoneLiability	1622000	usd
CY2021Q4	IMNN	Earnout Milestone Liability EarnoutMilestoneLiability	5396000	usd
CY2022	IMNN	Gain Loss From Change In Fair Value Of Earn Out Milestone Liability GainLossFromChangeInFairValueOfEarnOutMilestoneLiability	5396000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	256903	shares
CY2020Q4	IMNN	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	20.10
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	81111	shares
CY2021	IMNN	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercise In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExerciseInPeriodWeightedAverageExercisePrice	18.60
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	175792	shares
CY2021Q4	IMNN	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	20.96
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	7273	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	48.30
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.03	pure
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	117000	usd
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	107000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	172000	usd
CY2021	IMNN	Defined Contribution Plan Employer Discretionary Contribution Percent DefinedContributionPlanEmployerDiscretionaryContributionPercent	0.05	pure
CY2011	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	In 2011, the Company executed a lease (the “Lease”) with Brandywine Operating Partnership, L.P. (Brandywine), a Delaware limited partnership, for a 10,870 square foot premises located in Lawrenceville, New Jersey and relocated its offices to Lawrenceville, New Jersey from Columbia, Maryland. The Lease had an initial term of 66 months. In late 2015, Lenox Drive Office Park LLC, purchased the real estate and office building and assumed the Lease.
CY2011Q4	us-gaap	Area Of Land AreaOfLand	10870
CY2011Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P66M
CY2011Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2017-04-30
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	238609	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	238609	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7860	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	230749	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y7M9D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0998	pure

Files In Submission

Name	View Source	Status
0001493152-23-009604-index-headers.html	Edgar Link	pending
0001493152-23-009604-index.html	Edgar Link	pending
0001493152-23-009604.txt	Edgar Link	pending
0001493152-23-009604-xbrl.zip	Edgar Link	pending
ex10-25.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
imnn-20221231.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
imnn-20221231_def.xml	Edgar Link	unprocessable
imnn-20221231_lab.xml	Edgar Link	unprocessable
imnn-20221231_cal.xml	Edgar Link	unprocessable
imnn-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMNN
Imunon, Inc. Stock $imnn

2023 Q1 Form 10-K Financial Statement

#000149315223009604 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMNN Imunon, Inc. Stock $imnn

2023 Q1 Form 10-K Financial Statement

#000149315223009604 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMNN
Imunon, Inc. Stock $imnn